Hydrocephalus Shunts Market Scope And Analysis

  • Report Code : TIPRE00028558
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 205
Buy Now

Hydrocephalus Shunts Market Analysis and Scope (2022 to 2028)

Buy Now

Hydrocephalus Shunts Market Report Hydrocephalus Shunts Market Size and Share Hydrocephalus Shunts Market Scope and Analysis

Hydrocephalus Shunts Market Report Scope

Report Attribute Details
Market size in 2021 US$ 286.19 Million
Market Size by 2028 US$ 360.01 Million
Global CAGR (2021 - 2028) 3.4%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Age Group
  • Pediatric and Adults
By Type
  • Ventriculo-Peritoneal
  • Ventriculo-Atrial
  • Ventriculo-Pleural
  • Lumbo-Peritoneal
By Product
  • Hydrocephalus Valves
  • Hydrocephalus Catheters
  • Neuronavigation Systems
By End User
  • Hospitals
  • Ambulatory Surgical Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • B Braun Melsungen AG CHRISTOPH MIETHKE GMBH CO KG
  • Sophysa
  • HpBio Pr teses inc
  • Integra LifeSciences Holdings Corporation
  • KANEKA MEDIX CORP
  • Medtronic
  • Natus Medical Incorporated
  • Spiegelberg GmbH Co KG
  • Desu Medical
    		•

    End User Insights

    Based on end user, the hydrocephalus shunts market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment held the largest market share in 2021, and it is expected to register the highest CAGR of 3.8% during the forecast period.

    Organic strategies such as product launches and approvals are highly adopted growth strategies by companies in the hydrocephalus shunts market. A few of the recent key market developments are listed below.

    • In May 2020, Aesculap, Inc. in partnership with The Christoph Miethke GmbH & Co. KG (MIETHKE) announced the launch of the M.blue valve in the US. The M.blue valve features advanced gravitational technology, which is incorporated with a fixed differential pressure unit in one valve. It helps to provide a simple and position-dependent solution
    • In July 2019, Integra LifeSciences announced the acquisition of Arkis Biosciences Inc., a privately held company that offers a portfolio of neurosurgical devices, such as catheters. The acquisition of Arkis Biosciences strengthened Integra’s offerings in neurocritical care and Integra’s position as the world leader in advanced catheter technology.

    Company Profiles

    • B. Braun Melsungen AG (CHRISTOPH MIETHKE GMBH & CO. KG)
    • Sophysa
    • HpBio Próteses, inc.
    • Integra LifeSciences Holdings Corporation
    • KANEKA MEDIX CORP.
    • Medtronic Plc
    • Natus Medical Incorporated
    • Spiegelberg GmbH & Co. KG
    • Desu Medical